About GlycoMimetics, Inc

The mission of GlycoMimetics, Inc. ("GMI") is to develop novel small molecule therapeutics using a specialized platform technology based upon the roles that carbohydrates play in important biological processes. The company believes that carbohydrate mimics ("glycomimetic" compounds) represent an important new class of drugs. GMI is positioned to lead – more... 

Claim this company page
Headquarters
Gaithersburg Maryland, United States
Revenue
$750,000
Employees
11 to 50
Industry
Links
GlycoMimetics, Inc website